-
Resiquimod (R-848) is a drug that acts as an
immune response modifier, and has
antiviral and
antitumour activity. It is used as a
topical gel in the treatment...
- dermatology) is a TLR7 agonist, and its
successor resiquimod, is a TLR7 and TLR8 agonist. Recently,
resiquimod has been
explored as an
agent for
cancer immunotherapy...
- lesions. In
terms of treatment, a
number of
medications are
being studied.
Resiquimod is a TLR 7/8
agonist that
works similarly to imiquimod, but is 10 to 100...
-
found in
related drugs such as
imiquimod and
resiquimod. It is
structurally very
similar to
resiquimod differing only by an
oxygen for
nitrogen switch...
-
molecular formula C17H22N4O2 (molar m****: 314.389 g/mol) may
refer to:
Resiquimod Ralmitaront This set
index page
lists chemical structure articles ****ociated...
- for
antiviral and
antiallergic creams.
Dactolisib Imiquimod Gardiquimod Resiquimod Sumanirole Hemmi, H; Kaisho, T; Takeuchi, O; Sato, S; Sanjo, H; Hoshino...
-
Immunotherapy Deoxycholic acid, a
stimulator of
macrophages Imiquimod and
resiquimod,
activate immune cells through the toll-like
receptor 7 Kumar, S; Gupta...
- Gram-negative
bacteria TLR5 TLR5 "
Flagellin TLR6 TLR6 " TLR7 TLR7 "
resiquimod,
imiquimod TLR8 TLR8 " TLR9 TLR9 " CpG, DNA
enriched in cytosine:guanosine...
- D. (2013). "Electrospray
Encapsulation of Toll-Like
Receptor Agonist Resiquimod in
Polymer Microparticles for the
Treatment of
Visceral Leishmaniasis"...
- TMX-202
delivery via
liposomal formulation, as well as the
delivery of
resiquimod via
nanoparticles formed from beta-cyclodextrin. Loss-of-function variants...
